Cardiac and skeletal muscle development in P19 embryonal carcinoma cells - PubMed

Review

Cardiac and skeletal muscle development in P19 embryonal carcinoma cells

I S Skerjanc. Trends Cardiovasc Med. 1999 Jul.

Abstract

Mouse P19 embryonal carcinoma cells are pluripotent stem cells that can be maintained in culture in an undifferentiated state or can be induced to differentiate in vitro into multiple cell types. P19 cells aggregated in the presence of dimethylsulfoxide differentiate into spontaneously beating cardiomyocytes and bipolar skeletal myocytes that exhibit the biochemical and physiologic properties of their embryonic equivalents. P19 cells can be readily manipulated genetically, resulting in the loss or over-expression of a gene of interest. Because of this versatility, the P19 system is suited for examining the molecular mechanisms controlling the developmental decisions of stem cells differentiating into the skeletal or cardiac muscle lineage.

Similar articles

• Differentiation of beating cardiac muscle cells from a derivative of P19 embryonal carcinoma cells.

  Habara-Ohkubo A. Habara-Ohkubo A. Cell Struct Funct. 1996 Apr;21(2):101-10. doi: 10.1247/csf.21.101. Cell Struct Funct. 1996. PMID: 8790939

• A transfected H-ras oncogene does not inhibit differentiation of cardiac and skeletal muscle from embryonal carcinoma cells.

  Rudnicki MA, Reuhl KR, McBurney MW. Rudnicki MA, et al. Biochem Cell Biol. 1989 Sep;67(9):590-6. doi: 10.1139/o89-091. Biochem Cell Biol. 1989. PMID: 2679803

• P19 embryonal carcinoma cells.

  McBurney MW. McBurney MW. Int J Dev Biol. 1993 Mar;37(1):135-40. Int J Dev Biol. 1993. PMID: 8507558 Review.

• Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation.

  van der Heyden MA, Defize LH. van der Heyden MA, et al. Cardiovasc Res. 2003 May 1;58(2):292-302. doi: 10.1016/s0008-6363(02)00771-x. Cardiovasc Res. 2003. PMID: 12757864 Review.

Cited by

• Corexit-EC9527A Disrupts Retinol Signaling and Neuronal Differentiation in P19 Embryonal Pluripotent Cells.

  Chen Y, Reese DH. Chen Y, et al. PLoS One. 2016 Sep 29;11(9):e0163724. doi: 10.1371/journal.pone.0163724. eCollection 2016. PLoS One. 2016. PMID: 27684493 Free PMC article.

• P19 Cells Overexpressing Lhx1 Differentiate into the Definitive Endoderm by Recapitulating an Embryonic Developmental Pathway.

  Hasegawa A, Shirayoshi Y. Hasegawa A, et al. Yonago Acta Med. 2015 Mar;58(1):15-22. Epub 2015 Mar 27. Yonago Acta Med. 2015. PMID: 26190893 Free PMC article.

• Gli2 and MEF2C activate each other's expression and function synergistically during cardiomyogenesis in vitro.

  Voronova A, Al Madhoun A, Fischer A, Shelton M, Karamboulas C, Skerjanc IS. Voronova A, et al. Nucleic Acids Res. 2012 Apr;40(8):3329-47. doi: 10.1093/nar/gkr1232. Epub 2011 Dec 22. Nucleic Acids Res. 2012. PMID: 22199256 Free PMC article.

• Cross talk between hedgehog and bone morphogenetic proteins occurs during cardiomyogenesis in P19 cells.

  Gianakopoulos PJ, Skerjanc IS. Gianakopoulos PJ, et al. In Vitro Cell Dev Biol Anim. 2009 Oct;45(9):566-72. doi: 10.1007/s11626-009-9228-z. Epub 2009 Jul 8. In Vitro Cell Dev Biol Anim. 2009. PMID: 19585175

• Effects of miR-19b knockdown on the cardiac differentiation of P19 mouse embryonic carcinoma cells.

  Liu X, Yang L, Wang H, Xu G, Zhu S, Li M, Hu X, Zhu J, Zhu C, Xu J, Han S, Yu Z. Liu X, et al. Mol Med Rep. 2015 Apr;11(4):2504-12. doi: 10.3892/mmr.2014.3037. Epub 2014 Dec 3. Mol Med Rep. 2015. PMID: 25483911 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database